A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature

Dermatology

Volumn 213, Issue 4, 2006, Pages 345-349

  Stokkermans Dubois, J ^a   Jouary, T ^a   Vergier, B ^b   Delaunay, M M ^a   Taieb, A ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Cutaneous T cell lymphoma; Immunodeficiency; Lymphedema; Natural killer cell

Indexed keywords

CD3 ANTIGEN; CD30 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

AGED; ANTIGEN DETECTION; ARTICLE; CANCER SURVIVAL; CASE REPORT; EPSTEIN BARR VIRUS; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHEDEMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; SKIN BIOPSY; T CELL LYMPHOMA;

AGED; ANTIGENS, CD45; ANTIGENS, CD56; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LEG; LYMPHEDEMA; LYMPHOMA, T-CELL, CUTANEOUS; MALE; SKIN NEOPLASMS;

EID: 33751522603     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096201     Document Type: Article

References (12)

1. Ryan TJ, Mallon EC: Lymphatics and the processing of antigen. Exp Dermatol 1995;13:485-492.
2. Willemze R, Jaffe ES, Burg G, et al: WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
3. Santucci M, Pimpinelli N, Massi D, et al: Cytotoxic/ natural killer cell cutaneous lymphomas: report of the EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003;97:610-627.
4. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al: Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001;19:2179-2188.
5. Child FJ, Mitchell TJ, Whittaker SJ, et al: Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK. Br J Dermatol 2003;148:507-515.
6. Savoia P, Fierro MT, Novelli M, et al: CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997;137:966-971.
7. Chan JK, Sin VC, Wong KF, et al: Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.
8. Bekkenk MW, Jansen PM, Meijer CJLM, Willemze R: CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15:1097-1108.
9. Greer JP, Kinney MC, Loughran TPJ: T cell and NK cell lymphoproliferative disorders. Hematology 2001;1:259-281.
10. Gniadecki R, Rossen K, Ralfkier E, et al: CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Arch Dermatol 2004;140:427-436.
11. Dereure O: Lymphomes cutanés à cellules de phenotype NK et/ou cytotoxique. Ann Dermatol Venereol 2004;131:837-841.
12. ES Jaffe, NL Harris, H Stein, JW Vardiman: WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC press, 2001, pp 204-207.